Works matching Physiological effects of insulin


Results: 550
    1
    2
    3

    Timbe (Acaciella angustissima) Pods Extracts Reduce the Levels of Glucose, Insulin and Improved Physiological Parameters, Hypolipidemic Effect, Oxidative Stress and Renal Damage in Streptozotocin-Induced Diabetic Rats.

    Published in:
    Molecules, 2018, v. 23, n. 11, p. 2812, doi. 10.3390/molecules23112812
    By:
    • Rodríguez-Méndez, Adriana Jheny;
    • Carmen-Sandoval, Wendy;
    • Lomas-Soria, Consuelo;
    • Guevara-González, Ramón G.;
    • Reynoso-Camacho, Rosalía;
    • Villagran-Herrera, María Elena;
    • Salazar-Olivo, Luis;
    • Torres-Pacheco, Irineo;
    • Feregrino-Pérez, Ana A.
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12

    Issue Information.

    Published in:
    Human Psychopharmacology: Clinical & Experimental, 2018, v. 33, n. 2, p. 1, doi. 10.1002/hup.2636
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43

    Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study.

    Published in:
    2016
    By:
    • Rickels, Michael R.;
    • Ruedy, Katrina J.;
    • Foster, Nicole C.;
    • Piché, Claude A.;
    • Dulude, Hélène;
    • Sherr, Jennifer L.;
    • Tamborlane, William V.;
    • Bethin, Kathleen E.;
    • DiMeglio, Linda A.;
    • Wadwa, R. Paul;
    • Ahmann, Andrew J.;
    • Haller, Michael J.;
    • Nathan, Brandon M.;
    • Marcovina, Santica M.;
    • Rampakakis, Emmanouil;
    • Linyan Meng;
    • Beck, Roy W.;
    • Meng, Linyan;
    • T1D Exchange Intranasal Glucagon Investigators
    Publication type:
    journal article
    44
    45
    46
    47
    48
    49

    Advancing Basal Insulin Replacement in Type 2 Diabetes Inadequately Controlled With Insulin Glargine Plus Oral Agents: A Comparison of Adding Albiglutide, a Weekly GLP-1 Receptor Agonist, Versus Thrice-Daily Prandial Insulin Lispro.

    Published in:
    Diabetes Care, 2014, v. 37, n. 8, p. 2317, doi. 10.2337/dc14-0001
    By:
    • Rosenstock, Julio;
    • Fonseca, Vivian A.;
    • Gross, Jorge L.;
    • Ratner, Robert E.;
    • Ahrén, Bo;
    • Chow, Francis C. C.;
    • Yang, Fred;
    • Miller, Diane;
    • Johnson, Susan L.;
    • Stewart, Murray W.;
    • Leiter, Lawrence A.
    Publication type:
    Article
    50